Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma
Krejcik, Jakub, Casneuf, Tineke, Nijhof, Inger S., Verbist, Bie, Bald, Jaime, Plesner, Torben, Syed, Khaja, Liu, Kevin, van de Donk, Niels W.C.J., Weiss, Brendan M., Ahmadi, Tahamtan, Lokhorst, Henk M., Mutis, Tuna, Sasser, A.Kate
Published in Blood (21.07.2016)
Published in Blood (21.07.2016)
Get full text
Journal Article
Deep immune profiling of patients treated with lenalidomide and dexamethasone with or without daratumumab
Casneuf, Tineke, Adams, 3rd, Homer C, van de Donk, Niels W C J, Abraham, Yann, Bald, Jaime, Vanhoof, Greet, Van der Borght, Koen, Smets, Tina, Foulk, Brad, Nielsen, Karl C, Rusbuldt, Joshua, Axel, Amy, Lysaght, Andrew, Ceulemans, Hugo, Stevenaert, Frederik, Usmani, Saad Z, Plesner, Torben, Avet-Loiseau, Herve, Nijhof, Inger, Mutis, Tuna, Schecter, Jordan M, Chiu, Christopher, Bahlis, Nizar J
Published in Leukemia (01.02.2021)
Published in Leukemia (01.02.2021)
Get full text
Journal Article
High‐Parameter Mass Cytometry Evaluation of Relapsed/Refractory Multiple Myeloma Patients Treated with Daratumumab Demonstrates Immune Modulation as a Novel Mechanism of Action
Adams, Homer C., Stevenaert, Frederik, Krejcik, Jakub, Van der Borght, Koen, Smets, Tina, Bald, Jaime, Abraham, Yann, Ceulemans, Hugo, Chiu, Christopher, Vanhoof, Greet, Usmani, Saad Z., Plesner, Torben, Lonial, Sagar, Nijhof, Inger, Lokhorst, Henk M., Mutis, Tuna, Donk, Niels W.C.J., Sasser, Amy Kate, Casneuf, Tineke
Published in Cytometry. Part A (01.03.2019)
Published in Cytometry. Part A (01.03.2019)
Get full text
Journal Article
Monitoring multiple myeloma patients treated with daratumumab: teasing out monoclonal antibody interference
McCudden, Christopher, Axel, Amy E, Slaets, Dominique, Dejoie, Thomas, Clemens, Pamela L, Frans, Sandy, Bald, Jaime, Plesner, Torben, Jacobs, Joannes F M, van de Donk, Niels W C J, Moreau, Philippe, Schecter, Jordan M, Ahmadi, Tahamtan, Sasser, A Kate
Published in Clinical chemistry and laboratory medicine (01.06.2016)
Published in Clinical chemistry and laboratory medicine (01.06.2016)
Get full text
Journal Article
Abstract 3636: Potent antitumor activity of duvortuxizumab, a CD19 x CD3 DART® molecule, in lymphoma models
Izhak, Liat, Cullen, Dana E., Elgawly, Maha, Luistro, Leopoldo, Johnson, Syd, Bald, Jaime, Sasser, A Kate, Balasubramanian, Sriram
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Get full text
Journal Article
Daratumumab in Combination with Lenalidomide Plus Dexamethasone Induces Clonality Increase and T-Cell Expansion: Results from a Phase 3 Randomized Study (POLLUX)
Chiu, Christopher, Casneuf, Tineke, Axel, Amy, Lysaght, Andrew, Bald, Jaime, Khokhar, Nushmia Z, Plesner, Torben, Usmani, Saad Z, Goldschmidt, Hartmut, Ahmadi, Tahamtan, Chan, Kenneth, Sasser, A. Kate
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
Assessing clinical response in multiple myeloma (MM) patients treated with monoclonal antibodies (mAbs): Validation of a daratumumab IFE reflex assay (DIRA) to distinguish malignant M-protein from therapeutic antibody
McCudden, Christopher, Axel, Amy, Slaets, Dominique, Frans, Sandy, Bald, Jaime, Schecter, Jordan Mark, Ahmadi, Tahamtan, Plesner, Torben, Sasser, Kate
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Serum Proteomic Analysis of Multiple Myeloma Subjects Treated with Daratumumab Monotherapy
Casneuf, Tineke, Lysaght, Andrew, LeFave, Clare, Bald, Jaime, Weiss, Brendan, van de Donk, Niels W.C.J., Lokhorst, Henk M., Ahmadi, Tahamtan, Sasser, A. Kate
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article
The Effect of Clinically Relevant Concentrations of Daratumumab on the Performance of Freelite® Immunoassays
Jenner, Ellen, Evans, Josie, Axel, Amy, Bald, Jaime, Sasser, Kate, Chiu, Christopher, Berlanga, Oscar, Harding, Stephen
Published in Clinical lymphoma, myeloma and leukemia (01.02.2017)
Published in Clinical lymphoma, myeloma and leukemia (01.02.2017)
Get full text
Journal Article
Immunomodulatory Effects and Adaptive Immune Response to Daratumumab in Multiple Myeloma
Krejcik, Jakub, Casneuf, Tineke, Nijhof, Inger, Verbist, Bie, Bald, Jaime, Plesner, Torben, Liu, Kevin, van de Donk, Niels W.C.J., Weiss, Brendan, Ahmadi, Tahamtan, Lokhorst, Henk M., Mutis, Tuna, Sasser, A. Kate
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article
High-Parameter Mass Cytometry (CyTOF) Evaluation of Relapsed/Refractory Multiple Myeloma (MM) Pts (Pts) Treated with Daratumumab Supports Immune Modulation As a Novel Mechanism of Action
Adams, Homer, Stevenaert, Frederik, Krejcik, Jakub, Van der Borght, Koen, Casneuf, Tineke, Smets, Tina, Bald, Jaime, Abraham, Yann, Ceulemans, Hugo, Vanhoof, Greet, Ahmadi, Tahamtan, Usmani, Saad Z, Plesner, Torben, Lonial, Sagar, van Kessel-Welmers, Berris, Lokhorst, Henk M., Mutis, Tuna, van de Donk, Niels W.C.J., Sasser, A. Kate
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
Response to: Interference of daratumumab on the serum protein electrophoresis
McCudden, Christopher, Axel, Amy E., Slaets, Dominique, Dejoie, Thomas, Clemens, Pamela, Frans, Sandy, Bald, Jaime, Plesner, Torben, Jacobs, Joannes F.M., van de Donk, Niels W.C.J., Moreau, Philippe, Schecter, Jordan M., Ahmadi, Tahamtan, Sasser, A. Kate
Published in Clinical chemistry and laboratory medicine (01.02.2017)
Published in Clinical chemistry and laboratory medicine (01.02.2017)
Get full text
Journal Article